Kuru

Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders: Second Edition

Volumn , Issue , 2011, Pages 378-380

  Mclean, Catriona Ann ^a  

^a ALFRED HOSPITAL   (Australia)

Author keywords

CJD; Creutzfeldt Jakob disease; Kuru; Prion protein; Spongiform encephalopathies

Indexed keywords

EID: 84860901453     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444341256.ch38     Document Type: Chapter

References (18)

1. Alpers M. Kuru:implications of its transmissibility for the interpretation of its changing epidemiological pattern. In:Bailey O, Smith D (eds) The Central Nervous System:Some Experimental Models of Neurological Diseases. International Academy of Pathology Monograph No 9. Baltimore, MD:Williams and Wilkins, 1968, pp. 234-251.
2. Alpers M. The epidemiology of kuru:monitoring the epidemic from its peak to its end. Philos Trans Roy Soc Lond B Biol Sci 2008; 363:3707-3713.
3. Collinge J, Whitfield J, McKintosh E et al. A clinical study of kuru patients with long incubation periods at the end of the epidemic in Papua New Guinea. Philos Trans Roy Soc Lond B Biol Sci, 2008; 363:3725-3739.
4. Parchi P, Capellari S, Chen SG, Petersen RB, Gambetti P. Typing prion isoforms. Nature 1997; 386:232-234.
5. Hainfellner JA, Liberski PP, Guiroy DC et al. Pathology and immuncytochemistry of a kuru brain. Brain Pathol 1997; 7:547-553.
6. Lantos P, Bhatia K, Doey LJ et al. Is the neuropathology of new variant Creutzfeldt-Jakob disease and kuru similar? Lancet 1997; 350:187-188.
7. Cervenáková L, Goldfarb LG, Garruto R, Lee HS, Gajdusek, DC, Brown P. Phenotype-genotype studies in kuru:implications for new variant Creutzfeldt-Jakob disease. Proc Natl Acad Sci USA 1998; 95:13239-13241.
8. McLean CA, Ironside JW, Alpers MP et al. Comparative neuropathology of Kuru with the new variant of Creutzfeldt-Jakob disease:evidence for strain of agent predominating over genotype of host. Brain Pathol 1998; 8:429-437.
9. Lee H-S, Brown P, Cervenáková L et al. Increased susceptibility to kuru of carriers of the PRNP129 methionine/methionine genotype. J Infect Dis 2001; 183:192-196.
10. Mead S, Whitfield J, Poulter M et al. A novel protective prion protein variant that colocalises with Kuru exposure. N Engl J Med 2009; 361 (21):2056-2065.
11. Beck E, Daniel P. Kuru and Creutzfeldt-Jakob disease:neuropathological lesions and their significance. In:Prusiner SB, Hadlow WJ (eds) Slow Transmissible Diseases of the Nervous System. New York:Academic Press, 1979, pp 253-270.
12. Fowler M, Robertson EG. Observations on kuru. III Pathological features in five cases. Australasian Ann Med 1958; 8:16-26.
13. Kakulas B, Lecours A, Gajdusek D. Further observations on the pathology of Kuru. J Neuropathol Exp Neurol 1967; 26:85-97.
14. Klatzo I, Gajdusek D, Zigas V. Pathology of Kuru. Lab Invest 1959; 8:799-847.
15. Neumann M, Gajdusek D, Zigas V. Neuropathological findings in exotic neurologic disorders among natives of the highlands of New Guinea. J Neuropath Exp Neurol 1964; 23:486-507.
16. Brandner S, Whitfield J, Boone K et al. Central and peripheral pathology of kuru:pathological analysis of a recent case and comparison with other forms of human prion disease. Philos Trans Roy Soc Lond B Biol Sci 2008; 363:3755-3763.
17. Parchi P, Castellani R, Capellari S et al. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 1996; 39:767-778.
18. Will RG, Ironside JW, Zeidler M et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996; 347:921-925.